Today, December 12, 2024, the FDA has canceled its ongoing trial of the mRNA RSV vaccine due to 3x the occurrence of severe RSV disease in response to placebo.
6 Likes
Today, December 12, 2024, the FDA has canceled its ongoing trial of the mRNA RSV vaccine due to 3x the occurrence of severe RSV disease in response to placebo.